Effect of ethanol on the binding of warfarin enantiomers to human serum albumin

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 4, 2007, Pages 826-829

  Tatsumi, Akitoshi ^a,b   Kadobayashi, Muneo ^b   Iwakawa, Seigo ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^b HYOGO COLLEGE OF MEDICINE HOSPITAL   (Japan)

Author keywords

Commercial albumin preparation; Ethanol; Human serum albumin; Protein binding; Stereoselectivity; Warfarin

Indexed keywords

2 PROPANOL; ALCOHOL; HUMAN SERUM ALBUMIN; PROPANOL; WARFARIN;

ARTICLE; BINDING AFFINITY; DRUG BINDING SITE; DRUG EFFECT; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; ENANTIOMER; FRACTIONATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROPHOBICITY; STEREOCHEMISTRY; ULTRAFILTRATION;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ETHANOL; HUMANS; PROTEIN BINDING; SERUM ALBUMIN; STEREOISOMERISM; WARFARIN;

EID: 34147120799     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.826     Document Type: Article

References (22)

1. O'Reilly R. A., Clin. Pharmacol. Ther., 16, 348-354 (1974).
2. O'Reilly R. A., Aggeler P. M., Leong L. S., Thromb. Diath. Haemorrh., 1, 1-22 (1964).
3. Yacobi A., Levy G., J. Pharmacokin. Biopharm., 5, 123-131 (1977).
4. Rege B. D., Kao J. P. Y., Polli J. E., Eur. J. Pharm. Sci., 16, 237-246 (2002).
5. Wandel C., Kim R. B., Stein M., Clin. Pharmacol. Ther., 73, 394-396 (2003).
6. Grindel J. M., Jaworski T., Emanuele R. M., Culbreth P., Biopharm. Drug Dispos., 23, 87-103 (2002).
7. Ha C. E., Petersen C. E., Park D. S., Harohalli K., Bhagavan N. V., J. Biomed. Sci., 7, 114-121 (2000).
8. Olsen H., Andersen A., Nordbo A., Kongsgaard U. E., Bormer O. P., BMC Clin. Pharmacol., 4, 4 (2004); doi:10.1186/1472-6904-4-04.
9. Borga O., Borga B., J. Pharmacokin. Biopharm., 25, 63-77 (1997).
10. Takahashi H., Kashima T., Nomoto S., Iwade K., Tainaka H., Shimizu T., Nomizo Y., Muramoto N, Kimura S., Echizen H., Pharmacogenetics, 8, 365-373 (1998).
11. He X. M., Carter D. C., Nature (London), 358, 209-215 (1992).
12. Lin S. Y., Wei Y. S., Li M. J., Wang S. L., Eur. J. Pharm. Biopharm., 57, 457-464 (2004).
13. Fitos I., Visy J., Kardos J., Chirality, 14, 442-448 (2002).
14. Giannini D. D., Chan K. K., Roberts J. D., Proc. Natl. Acad. Sci. U.S.A., 71, 4221-4223 (1974).
15. Petitpas I., Bhattacharya A. A., Twine S., East M., Curry S., J. Biol. Chem., 276, 22804-22809 (2001).
16. Moser A. C., Kingsbury C., Hage D. S., J. Pharm. Biomed. Anal., 41, 1101-1109 (2006).
17. Mignot I., Presle N., Lapicque F., Monot C., Dropsy R., Netter P., Chirality, 8, 271-280 (1996).
18. Vorum H., Honore B., J. Pharm. Pharmacol., 48, 870-875 (1996).
19. Birkett D. J., Myers S. P., Sudlow G., Mol. Pharmacol., 13, 987-992 (1977).
20. Wilding G., Feldhoff R. C., Vesell E. S., Biochem. Pharmacol., 26, 1143-1146 (1977).
21. Birkett D. J., Myers S. P., Sudlow G., Clin. Clim. Acta, 85, 253-258 (1978).
22. Murray R. K., Granner D. K., Mayes P. A., Rodwell V. W., "Harper's Biochemistry," 24th ed., Appleton and Lange, Connecticut, 1996.